TYPHOID
Mr. Kuldeep Vyas
M.Sc. Community Health Nursing
1Kuldeep Vyas M.Sc.
CHN
TYPHOID
• Typhoid fever is due to systemic
infection mainly by Salmonella typhi
• Salmonella typhi infection is
found only in men
• The disease is clinically
characterized by a typical
continuous fever for 2-3 weeks,
with relative bradycardia with
involvement of lymphoid tissues
and considerable constitutional
symptoms
• The term “ENTERIC FEVER” includes
both typhoid and Para typhoid fevers
• The disease may occur
sporadically, epidemically or
endemically
2Kuldeep Vyas M.Sc.
CHN
EPIDEMIOLOGICAL DETERMINANTS
• AGENT:
1. Salmonella typhi is the major cause of entric
fever
2. S.para A & S.para B are relatively infrequent
TYPHOIDBACILLI
3Kuldeep Vyas M.Sc.
CHN
4Kuldeep Vyas M.Sc.
CHN
• S.typhi has three main antigens : O, H & Vi and
a number of phage types
• S.typhi survives intra cellularly in the tissues of
various organs
• It is readily killed by drying,
pasteurization and common
disinfectants
• The factors which influence the onset of
typhoid fever in man are the infecting dose
and virulence of the organism
• RESERVOIR OF INFECTION: Man is the only
known reservoir of infection (via cases &
carriers)
• CASES: A case is infectious as long as bacilli
appears in stools or urine
• CARRIERS: The carriers may be temporary
(incubatory, convalescent) or chronic
• Convalescent carriers excrete bacilli for 6-8
weeks (after which their numbers diminish
rapidly by the end of three months)
5Kuldeep Vyas M.Sc.
CHN
• Persons who excrete bacilli for more than one
year are after clinical attack are called chronic
carriers
• In most chronic carriers the bacilli exists in
gall bladder and in the billiary tract. A chronic
carrier may excrete the bacili for several years
(may be as long as 50 years)
• A famous case of “Typhoid Mary” who
gave raise to 1300 cases in her life time
is an example for a chronic carrier
state
• Faecal carriers are more common than
urinary carriers
6Kuldeep Vyas M.Sc.
CHN
SOURCE OFINFECTION
• The primary sources of infection are faeces
and urine of cases or carriers
• The secondary sources include contaminated
water, food, fingers and flies
HOST FACTORS
• AGE: Typhoid fever may occur at any age
• GENDER: Males are more
affected than females
• IMMUNITY: All ages are
susceptible to infection
• The host factors that contributes to resistance
to the bacilli are gastric acidity & local
intestinal immunity
7Kuldeep Vyas M.Sc.
CHN
ENVIRONMENTAL& SOCIAL FACTORS
• Enteric fevers are observed all throughout the
year
• The peak incidence is reported during July-
September
• Vegetables grown in sewage farmlands or
washed in contaminated water are positive
health hazard
• Typhoid bacilli grow rapidly in milk without
altering in taste or appearance in anyway, in
which case ingestion of such raw milk poses a
threat to the consumer
• These factors are compounded by such social
factors as pollution of drinking water supplies,
open air defecation and urination, low
standards of food and personal hygiene and
health ignorance
• Therefore typhoid fever may be regarded as an
index of general sanitation in any country
8Kuldeep Vyas M.Sc.
CHN
INCUBATIONPERIOD
• Usually 10-14 days
• But the it can be as short as 3 days or as long as
3 weeks, depending on the dose of bacilli
ingested
MODE OFTRANSMISSION
• Typhoid fever is transmitted via the faecal-oral
route or urine- oral routes
• This may take place directly through soiled
hands contaminated with faeces or urine of
cases or carriers or indirectly by the ingestion
of contaminated water, milk, food or through
flies
9Kuldeep Vyas M.Sc.
CHN
DYNAMICS OF TRANSMISSION
10Kuldeep Vyas M.Sc.
CHN
CLINICAL FEATURES
• The onset is insidious, but in children may be abrupt
with chills and high fever
• During the prodromal stage , there is malaise,
headache, cough and sore throat often with
abdominal pain and constipation
• The fever ascends in step ladder fashion
• After about 7-10 days, the fever reaches a plateau
and the patient looks toxic appearing exhausted
and often prostrated
• There may be marked constipation, especially in the
early stages or “pea soup diarrhoea”
• There is marked abdominal distension
• There is leukopenia and blood, urine and stool culture
is positive for salmonella
• If there are no complications the patient’s condition
improves over 7-10 days
• However relapse may occur for up to 2 weeks after
termination of therapy
• During early phase, physical findings are few
• Later splenomegaly, abdominal distension and
tenderness, relative bradycardia, dicrotic pulse and
ocassionaly meningsmus appear
• The rash (rose spots)commonly appear during the
second week of the disease
• The individual spot , found principally on the trunk, is
a pink papule 2-3 mm in diameter that fades on
pressure. It disappears in in 3-4 days 11Kuldeep Vyas M.Sc.
CHN
ROSESPOTS
• Serious complication occur in up to 10 percent
of patients (especially those who have been ill
for longer than 2 weeks and who have not
received proper treatment)
• Intestinal haemorrhage is manifested by a
sudden drop in temperature and signs of
shock, followed by dark or fresh blood in the
stool
• Intestinal perforation is most likely to occur
during the third week
• Less frequent complications are urinary
retention, pneumonia, thrombophlebitis,
myocarditis, psychosis, cholecystitis, nephritis
and oeteomyelitis 12Kuldeep Vyas M.Sc.
CHN
LABORATORYDIAGNOSIS
• MICROBIOLOGICAL PROCEDURES
The definitive diagnosis of typhoid fever
depends on the isolation of the bacilli from
blood, bone marrow and stools. Blood culture
is the mainstay of diagnosis of this disease
SEROLOGICAL PROCEDURE
• Felix-Widal test measures
agglutinating antibody levels against
O & H antigens
• Usually “O” antibodies appear on day 6-8 and
“H” antibodies on day 10-12 after the onset
of disease
• The test is usually performed on an acute
serum (at first contact with the patient)
• The test has moderate sensitivity and
specificity
• It can be negative up to 30% of culture –
proven case of typhoid fever
• This may be because of prior antibiotic
therapy, that has blunted the antibody
response
13Kuldeep Vyas M.Sc.
CHN
NEW DIAGNOSTIC TESTS
• The IDL tubex test can detect specific IgM
antibodies in samples to S. Typhi
liposaccharide (LPS) antigen and the staining
of bound antibodies by anti-human IgM
antibody conjugated to colloidal dye particles
DIAGNOSISREGIMEN
14Kuldeep Vyas M.Sc.
CHN
CONTROL OF TYPHOID FEVER
• The control or elimination of the typhoid fever is
well within the scope of modern public health
• There are generally three lines of defence
against typhoid fever:
• 1. Control of reservoir
• 2. Control of sanitation
• 3. Immunization
CONTROL OF RESERVOIR
• The usual methods of control of reservoir are
their identification, isolation, treatment &
disinfection
• CASES: EARLY DIAGNOSIS–This is of vital
importance as the early symptoms are non-
specific
• Culture of blood and stools are important
investigations in the diagnosis of cases
15Kuldeep Vyas M.Sc.
CHN
NOTIFICATION:
Notification must be done in areas where it is
mandatory
ISOLATION:
Since typhoid is an infectious disease the cases are
to be transferred to hospital
As a rule cases should be isolated till three
bacteriologically negative stools and urine
reports are obtained on three separate days
TREATMENT
• Flouroquinolones are widely regarded as the drug
of choice for the treatment of of typhoid fever
16Kuldeep Vyas M.Sc.
CHN
TREATMENT
17Kuldeep Vyas M.Sc.
CHN
• They are relatively inexpensive and well tolerated
and more reliably and effectively than
chloremphenicol, ampicillin, amoxicillin, and
trimethoprim & sulphamethoxazole
• Patients seriously ill and profoundly toxic
should be given Inj of hydrocortisone 100 mg
daily for 3-4 days
• DISINFECTION: stools and urine are the sole
sources f infection. They should be received in
in closed containers and disinfected with 5%
cresol for at least 2 hours
• All soiled clothes and linen should be
soaked in a solution of 2% chlorine and be
stream sterilized
• Doctors and nurses should disinfect
their hands
FOLLOWUP
• Examination of stools and urine should be
should be done for S.typhi 3-4 months after
discharge and again 12 months to prevent
development of carrier state
18Kuldeep Vyas M.Sc.
CHN
CARRIERS:
• Since carriers are the ultimate source of
infection, their identification and treatment is
one of the most radical ways of controlling
typhoid fever
• The following are the measures recommended:
• IDENTIFICATION: Carriers are identified by
cultural and serological examinations.
Duodenal drainage establishes the presence of
salmonella in the biliary tract of carriers
• The antibodies are present in about 80% of
chronic carriers
TREATMENTOF CARRIERS:
• The carriers should be given an intensive course
of ampicillin or amoxycillin (4-6 g a day)
together with probenecid (2g/day) for 6 weeks
19Kuldeep Vyas M.Sc.
CHN
20Kuldeep Vyas M.Sc.
CHN
• These drugs are concentrated in the bile and
may achieve eradication
• Chloromycetin is considered worthless for
clearing the carrier state
SUREGERY
• Cholecyctectomy with concomitant ampicillin
therapy has been regarded as the most
successful approach to the treatment of carriers
• Urinary carriers are eassy to treat, but
refractory cases may need nephrectomy when
one kidney is damaged and the other is
healthy
• SURVEILLANCE: The carriers should be
kept under surveillance. They should be
prevented from handling food, milk or water for
others
21Kuldeep Vyas M.Sc.
CHN
HEALTHEDUCATION
• Health education regarding washing of hands
with soap after defecations or urination and
before preparing food is an essential element
• In short, the management of carriers
continues to be an unsolved problem
• This is the crux of the problem, in the
elimination of typhoid
CONTROL OF SANITATION
• Protection and purification of drinking water
supplies, improvement of basic sanitation and
promotion of food hygiene are essential
measures to interrupt transmission of typhoid
fever
22Kuldeep Vyas M.Sc.
CHN
IMMUNIZATION
• Immunization is a complimentary approach in
the prevention of typhoid
• It yields the highest benefit to the money
spent
• Immunization against typhoid does not give
100% protection, but it definitely lowers both
the incidence and seriousness of the
infection
• It can be given at any age
upwards 2 years
• Immunization is recommended to those
who live in endemic areas, house hold
contacts and groups at risk of infection
such as school children and hospital staff,
travellers proceeding to endemic areas
and those attending melas and yatras
23Kuldeep Vyas M.Sc.
CHN
ANTI TYPHOIDVACCINES
• Two vaccines are available:
1. Vi polyssaccharide vaccine
2. The Type 21a vaccine
24Kuldeep Vyas M.Sc.
CHN
Vi POLYSSACCHARIDEVACCINE
• The vaccine is composed of purified Vi capsular
polysaccharide from the Ty2 S typhi strain and
elicits a T-cell independent IgG response that is
not boosted by additional doses
• The vaccine is administered sub cutaneously
or intra muscularly . The target value of each
single human dose is about 25 micro gram
of antigen
• The vaccine is stable for 6 months at 370 C and
for 2 years at 220 C
• The recommended storage temperature is 2-
8oC.The Vi vaccine does not elicit adequate
immune responses in children aged less than
2 yrs
• Only one dose is required and the vaccine
confers protection after 7 days of
vaccination
25Kuldeep Vyas M.Sc.
CHN
• To maintain protection revaccination is
recommended every three years.
• The vaccine can be co- administered with other
vaccines (such as yellow fever, and hepatitis A
and with routine childhood vaccinations)
• No serious adverse events and minimum
of local effects are associated with Vi
vaccination
• There are no contra indications to the vaccine
other than previous hypersensitivity reaction
to vaccine components
THE TYPE 21aVACCINE
• Is an orally administered live attenuated Ty2 strain
of S.typhi. The lyophilized vaccine is available as
enteric coated capsules
TYPE 21 aVACCINE:
26Kuldeep Vyas M.Sc.
CHN
• The vaccine has to be stored at 2-80C, it
retains potency for approximately 14 days
at 250 C
• The capsules are licensed for use in individuals
aged above 5 yrs
• The vaccine is administered every other day
(on 3 and 5 day) a 3-dose regimen is
recommended
• Protective immunity is achieved 7 days after
the last dose
• The recommendation is to repeat the series
every 3 years for people living in endemic
areas and every year for individuals travelling
from non endemic to endemic areas
27Kuldeep Vyas M.Sc.
CHN
28Kuldeep Vyas M.Sc.
CHN
29Kuldeep Vyas M.Sc.
CHN
30Kuldeep Vyas M.Sc.
CHN

Typhoid (Enteric fever)

  • 1.
    TYPHOID Mr. Kuldeep Vyas M.Sc.Community Health Nursing 1Kuldeep Vyas M.Sc. CHN
  • 2.
    TYPHOID • Typhoid feveris due to systemic infection mainly by Salmonella typhi • Salmonella typhi infection is found only in men • The disease is clinically characterized by a typical continuous fever for 2-3 weeks, with relative bradycardia with involvement of lymphoid tissues and considerable constitutional symptoms • The term “ENTERIC FEVER” includes both typhoid and Para typhoid fevers • The disease may occur sporadically, epidemically or endemically 2Kuldeep Vyas M.Sc. CHN
  • 3.
    EPIDEMIOLOGICAL DETERMINANTS • AGENT: 1.Salmonella typhi is the major cause of entric fever 2. S.para A & S.para B are relatively infrequent TYPHOIDBACILLI 3Kuldeep Vyas M.Sc. CHN
  • 4.
  • 5.
    • S.typhi hasthree main antigens : O, H & Vi and a number of phage types • S.typhi survives intra cellularly in the tissues of various organs • It is readily killed by drying, pasteurization and common disinfectants • The factors which influence the onset of typhoid fever in man are the infecting dose and virulence of the organism • RESERVOIR OF INFECTION: Man is the only known reservoir of infection (via cases & carriers) • CASES: A case is infectious as long as bacilli appears in stools or urine • CARRIERS: The carriers may be temporary (incubatory, convalescent) or chronic • Convalescent carriers excrete bacilli for 6-8 weeks (after which their numbers diminish rapidly by the end of three months) 5Kuldeep Vyas M.Sc. CHN
  • 6.
    • Persons whoexcrete bacilli for more than one year are after clinical attack are called chronic carriers • In most chronic carriers the bacilli exists in gall bladder and in the billiary tract. A chronic carrier may excrete the bacili for several years (may be as long as 50 years) • A famous case of “Typhoid Mary” who gave raise to 1300 cases in her life time is an example for a chronic carrier state • Faecal carriers are more common than urinary carriers 6Kuldeep Vyas M.Sc. CHN
  • 7.
    SOURCE OFINFECTION • Theprimary sources of infection are faeces and urine of cases or carriers • The secondary sources include contaminated water, food, fingers and flies HOST FACTORS • AGE: Typhoid fever may occur at any age • GENDER: Males are more affected than females • IMMUNITY: All ages are susceptible to infection • The host factors that contributes to resistance to the bacilli are gastric acidity & local intestinal immunity 7Kuldeep Vyas M.Sc. CHN
  • 8.
    ENVIRONMENTAL& SOCIAL FACTORS •Enteric fevers are observed all throughout the year • The peak incidence is reported during July- September • Vegetables grown in sewage farmlands or washed in contaminated water are positive health hazard • Typhoid bacilli grow rapidly in milk without altering in taste or appearance in anyway, in which case ingestion of such raw milk poses a threat to the consumer • These factors are compounded by such social factors as pollution of drinking water supplies, open air defecation and urination, low standards of food and personal hygiene and health ignorance • Therefore typhoid fever may be regarded as an index of general sanitation in any country 8Kuldeep Vyas M.Sc. CHN
  • 9.
    INCUBATIONPERIOD • Usually 10-14days • But the it can be as short as 3 days or as long as 3 weeks, depending on the dose of bacilli ingested MODE OFTRANSMISSION • Typhoid fever is transmitted via the faecal-oral route or urine- oral routes • This may take place directly through soiled hands contaminated with faeces or urine of cases or carriers or indirectly by the ingestion of contaminated water, milk, food or through flies 9Kuldeep Vyas M.Sc. CHN
  • 10.
  • 11.
    CLINICAL FEATURES • Theonset is insidious, but in children may be abrupt with chills and high fever • During the prodromal stage , there is malaise, headache, cough and sore throat often with abdominal pain and constipation • The fever ascends in step ladder fashion • After about 7-10 days, the fever reaches a plateau and the patient looks toxic appearing exhausted and often prostrated • There may be marked constipation, especially in the early stages or “pea soup diarrhoea” • There is marked abdominal distension • There is leukopenia and blood, urine and stool culture is positive for salmonella • If there are no complications the patient’s condition improves over 7-10 days • However relapse may occur for up to 2 weeks after termination of therapy • During early phase, physical findings are few • Later splenomegaly, abdominal distension and tenderness, relative bradycardia, dicrotic pulse and ocassionaly meningsmus appear • The rash (rose spots)commonly appear during the second week of the disease • The individual spot , found principally on the trunk, is a pink papule 2-3 mm in diameter that fades on pressure. It disappears in in 3-4 days 11Kuldeep Vyas M.Sc. CHN
  • 12.
    ROSESPOTS • Serious complicationoccur in up to 10 percent of patients (especially those who have been ill for longer than 2 weeks and who have not received proper treatment) • Intestinal haemorrhage is manifested by a sudden drop in temperature and signs of shock, followed by dark or fresh blood in the stool • Intestinal perforation is most likely to occur during the third week • Less frequent complications are urinary retention, pneumonia, thrombophlebitis, myocarditis, psychosis, cholecystitis, nephritis and oeteomyelitis 12Kuldeep Vyas M.Sc. CHN
  • 13.
    LABORATORYDIAGNOSIS • MICROBIOLOGICAL PROCEDURES Thedefinitive diagnosis of typhoid fever depends on the isolation of the bacilli from blood, bone marrow and stools. Blood culture is the mainstay of diagnosis of this disease SEROLOGICAL PROCEDURE • Felix-Widal test measures agglutinating antibody levels against O & H antigens • Usually “O” antibodies appear on day 6-8 and “H” antibodies on day 10-12 after the onset of disease • The test is usually performed on an acute serum (at first contact with the patient) • The test has moderate sensitivity and specificity • It can be negative up to 30% of culture – proven case of typhoid fever • This may be because of prior antibiotic therapy, that has blunted the antibody response 13Kuldeep Vyas M.Sc. CHN
  • 14.
    NEW DIAGNOSTIC TESTS •The IDL tubex test can detect specific IgM antibodies in samples to S. Typhi liposaccharide (LPS) antigen and the staining of bound antibodies by anti-human IgM antibody conjugated to colloidal dye particles DIAGNOSISREGIMEN 14Kuldeep Vyas M.Sc. CHN
  • 15.
    CONTROL OF TYPHOIDFEVER • The control or elimination of the typhoid fever is well within the scope of modern public health • There are generally three lines of defence against typhoid fever: • 1. Control of reservoir • 2. Control of sanitation • 3. Immunization CONTROL OF RESERVOIR • The usual methods of control of reservoir are their identification, isolation, treatment & disinfection • CASES: EARLY DIAGNOSIS–This is of vital importance as the early symptoms are non- specific • Culture of blood and stools are important investigations in the diagnosis of cases 15Kuldeep Vyas M.Sc. CHN
  • 16.
    NOTIFICATION: Notification must bedone in areas where it is mandatory ISOLATION: Since typhoid is an infectious disease the cases are to be transferred to hospital As a rule cases should be isolated till three bacteriologically negative stools and urine reports are obtained on three separate days TREATMENT • Flouroquinolones are widely regarded as the drug of choice for the treatment of of typhoid fever 16Kuldeep Vyas M.Sc. CHN
  • 17.
  • 18.
    • They arerelatively inexpensive and well tolerated and more reliably and effectively than chloremphenicol, ampicillin, amoxicillin, and trimethoprim & sulphamethoxazole • Patients seriously ill and profoundly toxic should be given Inj of hydrocortisone 100 mg daily for 3-4 days • DISINFECTION: stools and urine are the sole sources f infection. They should be received in in closed containers and disinfected with 5% cresol for at least 2 hours • All soiled clothes and linen should be soaked in a solution of 2% chlorine and be stream sterilized • Doctors and nurses should disinfect their hands FOLLOWUP • Examination of stools and urine should be should be done for S.typhi 3-4 months after discharge and again 12 months to prevent development of carrier state 18Kuldeep Vyas M.Sc. CHN
  • 19.
    CARRIERS: • Since carriersare the ultimate source of infection, their identification and treatment is one of the most radical ways of controlling typhoid fever • The following are the measures recommended: • IDENTIFICATION: Carriers are identified by cultural and serological examinations. Duodenal drainage establishes the presence of salmonella in the biliary tract of carriers • The antibodies are present in about 80% of chronic carriers TREATMENTOF CARRIERS: • The carriers should be given an intensive course of ampicillin or amoxycillin (4-6 g a day) together with probenecid (2g/day) for 6 weeks 19Kuldeep Vyas M.Sc. CHN
  • 20.
  • 21.
    • These drugsare concentrated in the bile and may achieve eradication • Chloromycetin is considered worthless for clearing the carrier state SUREGERY • Cholecyctectomy with concomitant ampicillin therapy has been regarded as the most successful approach to the treatment of carriers • Urinary carriers are eassy to treat, but refractory cases may need nephrectomy when one kidney is damaged and the other is healthy • SURVEILLANCE: The carriers should be kept under surveillance. They should be prevented from handling food, milk or water for others 21Kuldeep Vyas M.Sc. CHN
  • 22.
    HEALTHEDUCATION • Health educationregarding washing of hands with soap after defecations or urination and before preparing food is an essential element • In short, the management of carriers continues to be an unsolved problem • This is the crux of the problem, in the elimination of typhoid CONTROL OF SANITATION • Protection and purification of drinking water supplies, improvement of basic sanitation and promotion of food hygiene are essential measures to interrupt transmission of typhoid fever 22Kuldeep Vyas M.Sc. CHN
  • 23.
    IMMUNIZATION • Immunization isa complimentary approach in the prevention of typhoid • It yields the highest benefit to the money spent • Immunization against typhoid does not give 100% protection, but it definitely lowers both the incidence and seriousness of the infection • It can be given at any age upwards 2 years • Immunization is recommended to those who live in endemic areas, house hold contacts and groups at risk of infection such as school children and hospital staff, travellers proceeding to endemic areas and those attending melas and yatras 23Kuldeep Vyas M.Sc. CHN
  • 24.
    ANTI TYPHOIDVACCINES • Twovaccines are available: 1. Vi polyssaccharide vaccine 2. The Type 21a vaccine 24Kuldeep Vyas M.Sc. CHN
  • 25.
    Vi POLYSSACCHARIDEVACCINE • Thevaccine is composed of purified Vi capsular polysaccharide from the Ty2 S typhi strain and elicits a T-cell independent IgG response that is not boosted by additional doses • The vaccine is administered sub cutaneously or intra muscularly . The target value of each single human dose is about 25 micro gram of antigen • The vaccine is stable for 6 months at 370 C and for 2 years at 220 C • The recommended storage temperature is 2- 8oC.The Vi vaccine does not elicit adequate immune responses in children aged less than 2 yrs • Only one dose is required and the vaccine confers protection after 7 days of vaccination 25Kuldeep Vyas M.Sc. CHN
  • 26.
    • To maintainprotection revaccination is recommended every three years. • The vaccine can be co- administered with other vaccines (such as yellow fever, and hepatitis A and with routine childhood vaccinations) • No serious adverse events and minimum of local effects are associated with Vi vaccination • There are no contra indications to the vaccine other than previous hypersensitivity reaction to vaccine components THE TYPE 21aVACCINE • Is an orally administered live attenuated Ty2 strain of S.typhi. The lyophilized vaccine is available as enteric coated capsules TYPE 21 aVACCINE: 26Kuldeep Vyas M.Sc. CHN
  • 27.
    • The vaccinehas to be stored at 2-80C, it retains potency for approximately 14 days at 250 C • The capsules are licensed for use in individuals aged above 5 yrs • The vaccine is administered every other day (on 3 and 5 day) a 3-dose regimen is recommended • Protective immunity is achieved 7 days after the last dose • The recommendation is to repeat the series every 3 years for people living in endemic areas and every year for individuals travelling from non endemic to endemic areas 27Kuldeep Vyas M.Sc. CHN
  • 28.
  • 29.
  • 30.